OmniStar Financial Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-6,806
Closed -$349K 118
2022
Q4
$349K Sell
6,806
-17,726
-72% -$850K 0.4% 82
2022
Q3
$1.07M Sell
24,532
-1,964
-7% -$95.4K 1.28% 25
2022
Q2
$1.39M Sell
26,496
-2,866
-10% -$146K 1.54% 17
2022
Q1
$1.52M Buy
29,362
+11,059
+60% +$574K 1.51% 15
2021
Q4
$1.08M Buy
18,303
+7,734
+73% +$383K 1.1% 27
2021
Q3
$454K Buy
+10,569
New +$468K 0.54% 73
2021
Q2
Sell
-23,845
Closed -$927K 161
2021
Q1
$864K Buy
23,845
+910
+4% +$32.3K 1.1% 32
2020
Q4
$844K Buy
22,935
+1,460
+7% +$53.6K 0.59% 58
2020
Q3
$748K Sell
21,475
-16,231
-43% -$569K 0.56% 58
2020
Q2
$1.17M Buy
37,706
+3,334
+10% +$113K 0.97% 36
2020
Q1
$1.06M Buy
34,372
+23,200
+208% +$791K 1.05% 29
2019
Q4
$415K Sell
11,172
-696
-6% -$24.8K 0.35% 85
2019
Q3
$405K Sell
11,868
-22,001
-65% -$800K 0.35% 81
2019
Q2
$1.39M Sell
33,869
-105
-0.3% -$4.17K 1.25% 29
2019
Q1
$1.37M Buy
33,974
+7,801
+30% +$312K 1.2% 33
2018
Q4
$1.08M Buy
26,173
+1,959
+8% +$81.3K 1.11% 41
2018
Q3
$1.01M Sell
24,214
-34,002
-58% -$1.31M 0.77% 47
2018
Q2
$2M Buy
58,216
+63
+0.1% +$2.15K 1.91% 14
2018
Q1
$1.96M Buy
58,153
+2,606
+5% +$89.6K 1.87% 17
2017
Q4
$1.91M Buy
+55,547
New +$1.89M 1.75% 16

Other funds holding PFE

OmniStar Financial Group's PFE Position: Q1 2023 in Review

OmniStar Financial Group sold out of Pfizer (PFE) in Q1 2023, closing a stake of 6,806 shares — an estimated $349K sold.

OmniStar Financial Group first reported a position in PFE in Q4 2017 and held it in 20 quarters. The position peaked at $2M in Q2 2018. 3,103 funds tracked by Wall St. Rank hold PFE as of Q1 2023.

  • OmniStar Financial Group reported no remaining Pfizer position as of Q1 2023 after selling out during the quarter.
  • OmniStar Financial Group sold 6,806 Pfizer shares in Q1 2023, an estimated $349K.
  • OmniStar Financial Group first reported a position in Pfizer in Q4 2017 and held it in 20 quarters.
  • OmniStar Financial Group's Pfizer position peaked at $2M in Q2 2018.
  • 3,103 funds tracked by Wall St. Rank held Pfizer as of Q1 2023.

Based on OmniStar Financial Group's 13F filing for Q1 2023, filed 1 May 2023.